Last week’s hot topic on Multiple Sclerosis was an article titled MS Researchers Create a Nanoparticle Drug Able to Stop Inflammation and Autoimmune Attacks in Mice, written by Margarida Azevedo.
The article is focused around the discovery of a mechanism to halt autoimmune disease damage and development of a novel class of drugs that triggers the mechanism, and which has the potential to treat autoimmune diseases like multiple sclerosis (MS) without impairing the normal and necessary activities of the immune system.
This study, led by Dr. Pere Santamaria, a professor in the Department of Microbiology, Immunology and Infectious Diseases at the University of Calgary Cumming School of Medicine, was recently published in the journal Nature and titled “Expanding antigen-specific regulatory networks to treat autoimmunity.”
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?